X0306 4 2022-06-30 0001645469 Monopar Therapeutics MNPR 0001333516 Tsuchimoto Kim R 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 false true false false Chief Financial Officer Common Stock 2022-06-30 4 M false 8913 A 14549 D Common Stock 2022-06-30 4 F false 3083 2.299 D 11466 D Restricted Stock Units 2022-06-30 4 M false 8913 0 D Common Stock 8913 68511 D Represents shares acquired on vesting and settlement of restricted stock units. On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. /s/ Kim R. Tsuchimoto 2022-07-01